Baillie Gifford & Company Has Lowered Its Dexcom (DXCM) Stake as Shares Rose; Dxp Enterprises New (DXPE) Valuation Rose While Algert Global Has Lowered Stake by $1.56 Million

May 18, 2018 - By Michael Collier

DexCom, Inc. (NASDAQ:DXCM) Logo

Peter Algert decreased its stake in Dxp Enterprises Inc New (DXPE) by 78.89% based on its latest 2017Q4 regulatory filing with the SEC. Algert Global Llc sold 53,875 shares as the company’s stock rose 33.72% while stock markets declined. The hedge fund run by Peter Algert held 14,417 shares of the capital goods company at the end of 2017Q4, valued at $426,000, down from 68,292 at the end of the previous reported quarter. Algert Global Llc who had been investing in Dxp Enterprises Inc New for a number of months, seems to be less bullish one the $700.07M market cap company. The stock increased 1.24% or $0.49 during the last trading session, reaching $40.29. About 5,407 shares traded. DXP Enterprises, Inc. (NASDAQ:DXPE) has risen 24.48% since May 18, 2017 and is uptrending. It has outperformed by 12.93% the S&P500.

Baillie Gifford & Company decreased its stake in Dexcom Inc (DXCM) by 3.93% based on its latest 2017Q4 regulatory filing with the SEC. Baillie Gifford & Company sold 227,050 shares as the company’s stock rose 24.71% while stock markets declined. The institutional investor held 5.55 million shares of the health care company at the end of 2017Q4, valued at $318.55M, down from 5.78 million at the end of the previous reported quarter. Baillie Gifford & Company who had been investing in Dexcom Inc for a number of months, seems to be less bullish one the $7.62B market cap company. The stock decreased 0.50% or $0.44 during the last trading session, reaching $86.47. About 5,307 shares traded. DexCom, Inc. (NASDAQ:DXCM) has declined 16.08% since May 18, 2017 and is downtrending. It has underperformed by 27.63% the S&P500.

More important recent DXP Enterprises, Inc. (NASDAQ:DXPE) news were published by: Globenewswire.com which released: “New Research: Key Drivers of Growth for Global Medical REIT, DXP Enterprises, SJW, FTI Consulting, Anthera …” on May 04, 2018, also Businesswire.com published article titled: “DXP Enterprises Reports First Quarter 2018 Results”, Businesswire.com published: “DXP Enterprises Appoints Gene Padgett Chief Accounting Officer” on May 15, 2018. More interesting news about DXP Enterprises, Inc. (NASDAQ:DXPE) was released by: Seekingalpha.com and their article: “DXP Enterprises’ (DXPE) CEO David Little on Q1 2018 Results – Earnings Call Transcript” with publication date: May 13, 2018.

Among 2 analysts covering DXP Enterprises (NASDAQ:DXPE), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. DXP Enterprises had 5 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was initiated by KeyBanc Capital Markets on Tuesday, July 21 with “Sector Weight”. On Friday, May 26 the stock rating was maintained by KeyBanc Capital Markets with “Sector Weight”. The firm has “Hold” rating by KeyBanc Capital Markets given on Friday, September 15. The rating was maintained by KeyBanc Capital Markets on Monday, October 16 with “Hold”. The stock has “Buy” rating by Stephens on Wednesday, March 21.

Algert Global Llc, which manages about $1.01B and $423.60M US Long portfolio, upped its stake in Appfolio Inc by 9,870 shares to 51,894 shares, valued at $2.15 million in 2017Q4, according to the filing. It also increased its holding in Spdr S&P 500 Etf Tr (SPY) by 6,006 shares in the quarter, for a total of 9,423 shares, and has risen its stake in Kraton Corporation (NYSE:KRA).

Since December 29, 2017, it had 0 insider buys, and 6 selling transactions for $2.72 million activity. 3,175 shares were sold by YEE KENT NEE HUNG, worth $124,936 on Thursday, March 29. The insider VINSON DAVID C sold 7,290 shares worth $291,600. $2.01 million worth of DXP Enterprises, Inc. (NASDAQ:DXPE) shares were sold by LITTLE DAVID R. 3,000 DXP Enterprises, Inc. (NASDAQ:DXPE) shares with value of $120,000 were sold by Jeffery John Jay.

Analysts await DXP Enterprises, Inc. (NASDAQ:DXPE) to report earnings on July, 24. They expect $0.27 earnings per share, up 17.39% or $0.04 from last year’s $0.23 per share. DXPE’s profit will be $4.69M for 37.31 P/E if the $0.27 EPS becomes a reality. After $0.24 actual earnings per share reported by DXP Enterprises, Inc. for the previous quarter, Wall Street now forecasts 12.50% EPS growth.

Investors sentiment decreased to 0.98 in Q4 2017. Its down 0.47, from 1.45 in 2017Q3. It is negative, as 11 investors sold DXPE shares while 38 reduced holdings. 13 funds opened positions while 35 raised stakes. 12.94 million shares or 0.89% more from 12.83 million shares in 2017Q3 were reported. 80,522 were accumulated by Morgan Stanley. Renaissance Technology Limited Liability Corp invested 0% in DXP Enterprises, Inc. (NASDAQ:DXPE). Missouri-based Amer Century has invested 0.02% in DXP Enterprises, Inc. (NASDAQ:DXPE). Amer International Gru Incorporated accumulated 0% or 12,541 shares. Macquarie Gru Ltd has 0% invested in DXP Enterprises, Inc. (NASDAQ:DXPE). Moreover, King Luther Capital Corp has 0.11% invested in DXP Enterprises, Inc. (NASDAQ:DXPE). Pnc Fincl Serv Grp Inc stated it has 311 shares. Principal Group has invested 0% in DXP Enterprises, Inc. (NASDAQ:DXPE). Texas Permanent School Fund stated it has 10,698 shares or 0% of all its holdings. Blackrock holds 1.99 million shares or 0% of its portfolio. Nantahala Limited Liability Company holds 617,750 shares or 0.81% of its portfolio. Savings Bank Of Montreal Can holds 0% or 738 shares in its portfolio. Pacific Glob Mngmt Com, a California-based fund reported 102,325 shares. Dimensional Fund Advsrs Lp reported 0.01% of its portfolio in DXP Enterprises, Inc. (NASDAQ:DXPE). Citigroup accumulated 19,419 shares.

Among 25 analysts covering Dexcom (NASDAQ:DXCM), 17 have Buy rating, 2 Sell and 6 Hold. Therefore 68% are positive. Dexcom had 77 analyst reports since August 6, 2015 according to SRatingsIntel. As per Thursday, July 13, the company rating was maintained by Cowen & Co. The firm has “Buy” rating given on Thursday, September 28 by Wedbush. As per Thursday, July 13, the company rating was maintained by Jefferies. On Friday, March 23 the stock rating was maintained by Piper Jaffray with “Buy”. The firm has “Buy” rating given on Wednesday, September 27 by Jefferies. Benchmark maintained DexCom, Inc. (NASDAQ:DXCM) rating on Wednesday, February 24. Benchmark has “Buy” rating and $86 target. Morgan Stanley maintained the shares of DXCM in report on Friday, May 4 with “Equal-Weight” rating. Canaccord Genuity maintained DexCom, Inc. (NASDAQ:DXCM) rating on Thursday, May 3. Canaccord Genuity has “Buy” rating and $85 target. On Wednesday, August 2 the stock rating was maintained by BMO Capital Markets with “Outperformer”. The firm has “Buy” rating by Canaccord Genuity given on Tuesday, June 6.

Since December 11, 2017, it had 0 insider buys, and 14 sales for $11.50 million activity. Balo Andrew K also sold $198,691 worth of DexCom, Inc. (NASDAQ:DXCM) shares. $559,095 worth of stock was sold by GREGG TERRANCE H on Thursday, February 15. On Tuesday, May 8 the insider SKYLER JAY S sold $2.68 million. SAYER KEVIN R sold $1.45M worth of stock. Leach Jacob Steven also sold $1.12 million worth of DexCom, Inc. (NASDAQ:DXCM) on Tuesday, May 8.

Analysts await DexCom, Inc. (NASDAQ:DXCM) to report earnings on August, 7. They expect $-0.20 earnings per share, down 25.00% or $0.04 from last year’s $-0.16 per share. After $-0.32 actual earnings per share reported by DexCom, Inc. for the previous quarter, Wall Street now forecasts -37.50% EPS growth.

Baillie Gifford & Company, which manages about $80.43B US Long portfolio, upped its stake in National Instruments Corp (NASDAQ:NATI) by 14,872 shares to 814,584 shares, valued at $33.91M in 2017Q4, according to the filing. It also increased its holding in Codexis (NASDAQ:CDXS) by 364,304 shares in the quarter, for a total of 1.84M shares, and has risen its stake in Vertex Pharmaceuticals (NASDAQ:VRTX).

More notable recent DexCom, Inc. (NASDAQ:DXCM) news were published by: Seekingalpha.com which released: “Premarket analyst action – healthcare” on May 11, 2018, also Profitconfidential.com with their article: “DXCM Stock Is on the Verge of Breaking Out Toward Higher Prices” published on May 09, 2018, Benzinga.com published: “Piper Jaffray: Tandem Diabetes Is Entering A ‘Goldilocks Period'” on May 14, 2018. More interesting news about DexCom, Inc. (NASDAQ:DXCM) were released by: Nasdaq.com and their article: “Here’s Why Tandem Diabetes Care, Inc. Is Rising Today” published on May 14, 2018 as well as Seekingalpha.com‘s news article titled: “DexCom (DXCM) Q1 2018 Results – Earnings Call Transcript” with publication date: May 03, 2018.

Investors sentiment decreased to 0.73 in Q4 2017. Its down 0.24, from 0.97 in 2017Q3. It dropped, as 44 investors sold DXCM shares while 97 reduced holdings. 48 funds opened positions while 55 raised stakes. 99.11 million shares or 0.83% more from 98.30 million shares in 2017Q3 were reported. Essex Inv Mgmt Co Limited Liability Corp reported 0.22% of its portfolio in DexCom, Inc. (NASDAQ:DXCM). Daiwa Grp owns 47,370 shares or 0.02% of their US portfolio. 2,387 were reported by Thompson Davis Company Inc. Moreover, Parametric Port Associates Limited Liability Company has 0.01% invested in DexCom, Inc. (NASDAQ:DXCM). Goldman Sachs Group Inc Inc, a New York-based fund reported 1.55M shares. Moreover, C Worldwide Holdg A S has 0.06% invested in DexCom, Inc. (NASDAQ:DXCM) for 71,687 shares. 25,748 were accumulated by Automobile Association. Frontier Management Llc reported 688,157 shares. Granahan Inv Mngmt Ma stated it has 25,835 shares or 0.12% of all its holdings. Aperio Group Limited Liability Corp has 18,894 shares. Arrowmark Colorado Limited Liability Company owns 1.20 million shares. The Pennsylvania-based Vanguard Gru has invested 0.02% in DexCom, Inc. (NASDAQ:DXCM). Victory Mngmt holds 733 shares. 301,000 are held by Bamco. Qs Invsts Limited Co owns 2,907 shares.

DXP Enterprises, Inc. (NASDAQ:DXPE) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>